Showing results (491-500 of 559) with videos related to

Sort By:
Pageof 56
Physical Review Letters|September 28, 2010
Coexistence and competition of magnetism and superconductivity on the nanometer scale in underdoped BaFe1.89Co0.11As2P Marsik, K W Kim, A Dubroka, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|July 24, 2007
Renal biopsy findings in the kingdom of bahrain: a 13-year retrospective studyAhmed Al Arrayed, Sara M George, A K Malik, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 5, 2017
Dust mite induces multiple polar T cell axes in human skinK Malik, B Ungar, S Garcet, et al.
Oncogene|January 18, 2012
Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathwaysA R Dallosso, B Øster, A Greenhough, et al.
Physical Review Letters|May 21, 2010
Dynamical response and confinement of the electrons at the LaAlO3/SrTiO3 interfaceA Dubroka, M Rössle, K W Kim, et al.
Allergy|October 31, 2017
Alopecia areata is characterized by expansion of circulating Th2/Tc2/Th22, within the skin-homing and systemic T-cell populationsT Czarnowicki, H Y He, H-C Wen, et al.
Agronomy for Sustainable Development|March 8, 2021
Social-ecological analysis of timely rice planting in Eastern IndiaAnton Urfels, Andrew J McDonald, Gerardo van Halsema, et al.
Transplantation|May 23, 2024
Does Time to Asystole in Donors After Circulatory Death Impact Recipient Outcome in Liver Transplantation?Abdullah K Malik, Samuel J Tingle, Chris Varghese, et al.
The Pediatric Infectious Disease Journal|May 1, 1999
Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unitR K Malik, M A Montecalvo, M R Reale, et al.
Investigational New Drugs|December 2, 2010
Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancerStefan Madajewicz, David M Waterhouse, Paul S Ritch, et al.
Pageof 56